ArticleThoracic cancer2018

Microwave ablation with continued EGFR tyrosine kinase inhibitor therapy prolongs disease control in non-small-cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors.

Xin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.